IPHA
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
IPHA Filings
Filing Date
Form Description
Form Type
2025-07-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-07-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-06-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-30
Form 144 - Report of proposed sale of securities
Ownership
2025-05-30 · Ownership
Form 144 - Report of proposed sale of securities
2025-05-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-05-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-05-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-05-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-05-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-15
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-05-15 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-13
Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript
Earnings Call
2025-05-13 · Earnings Call
Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript